
|Articles|November 1, 2002
Study results promising: Antibiotic product treats conjunctivitis effectively
Alameda, CA-InSite Vision Inc.'s antibiotic product ISV-401 has proved safe and effective for treating acute bacterial conjunctivitis in a phase II clinical study.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves veligrotug-vvze (Lumvoa) for thyroid eye disease across active and chronic stages
2
Lesion growth rate reduction tops retina specialists' geographic atrophy treatment priorities
3
Obstructive sleep apnea and glaucoma: What a 12.5-million-patient data set reveals
4
Bayer acquires Perfuse Therapeutics, partners with Iambic to expand ophthalmology and AI capabilities
5


























